יתרות מזומנים למניה אחת utahmed.com (UTMD)

Is it worth investing in Utah Medical Products (UTMD), given the optimization of sterile supplies and low shipping costs? The cash per share forecast provides the answer, and the 29.97 metric determines this level. Growth is driven by the expansion of B2B sales of specialized instruments. Stability is guaranteed by the integration of consumables into medical protocols, although access to new markets is limited by strict FDA control.
פילוחים אנליטיים של חברת Utah Medical Products (UTMD)

Stable plant utilization and cleanroom certification at Utah Medical Products (UTMD) ensure a predictable cash flow, which accumulates as liquid reserves. This free liquidity per share metric is calculated by dividing total cash holdings by the number of shares outstanding, allowing investors to assess financial stability and the potential for capital protection against market volatility.